1-5 of 5
Brian J. Wells, MD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Response to Comment on: Pantalone et al. The Risk of Overall Mortality in Patients With Type 2 Diabetes Receiving Glipizide, Glyburide, or Glimepiride Monotherapy: A Retrospective Analysis. Diabetes Care 2010;33:1224–1229

Kevin M. Pantalone, DO, Michael W. Kattan, PHD, Brian J. Wells, MD, MS, Robert S. Zimmerman, MD, FACE
Journal: Diabetes Care
Diabetes Care 2011;34(8):e139
https://doi.org/10.2337/dc11-0920
Published: 16 July 2011
View article titled, Response to Comment on: Pantalone et al. The Risk of Overall Mortality in Patients With Type 2 Diabetes Receiving Glipizide, Glyburide, or Glimepiride Monotherapy: A Retrospective Analysis. Diabetes Care 2010;33:1224–1229
Open the PDF for Response to Comment on: Pantalone et al. The Risk of Overall Mortality in Patients With Type 2 Diabetes Receiving Glipizide, Glyburide, or Glimepiride Monotherapy: A Retrospective Analysis. Diabetes Care 2010;33:1224–1229 in another window
Journal Articles

The Risk of Overall Mortality in Patients With Type 2 Diabetes Receiving Glipizide, Glyburide, or Glimepiride Monotherapy: A retrospective analysis

Kevin M. Pantalone, DO, Michael W. Kattan, PHD, Changhong Yu, MS, Brian J. Wells, MD, MS, Susana Arrigain, MA, Anil Jain, MD, Ashish Atreja, MD, MPH, Robert S. Zimmerman, MD, FACE
Journal: Diabetes Care
Diabetes Care 2010;33(6):1224–1229
https://doi.org/10.2337/dc10-0017
Published: 09 March 2010
View article titled, The Risk of Overall Mortality in Patients With Type 2 Diabetes Receiving Glipizide, Glyburide, or Glimepiride Monotherapy: <subtitle>A retrospective analysis</subtitle>
Open the PDF for The Risk of Overall Mortality in Patients With Type 2 Diabetes Receiving Glipizide, Glyburide, or Glimepiride Monotherapy: <subtitle>A retrospective analysis</subtitle> in another window
Journal Articles

Health Care and Productivity Costs Associated With Diabetic Patients With Macrovascular Comorbid Conditions

Alex Z. Fu, PHD, Ying Qiu, PHD, Larry Radican, PHD, Brian J. Wells, MD, MS
Journal: Diabetes Care
Diabetes Care 2009;32(12):2187–2192
https://doi.org/10.2337/dc09-1128
Published: 03 September 2009
View article titled, Health Care and Productivity Costs Associated With Diabetic Patients With Macrovascular Comorbid Conditions
Open the PDF for Health Care and Productivity Costs Associated With Diabetic Patients With Macrovascular Comorbid Conditions in another window
Includes: Supplementary data
Journal Articles

Predicting 6-Year Mortality Risk in Patients With Type 2 Diabetes: Response to Paul et al.

Brian J. Wells, MD, Anil Jain, MD, Susana Arrigain, MA, Changhong Yu, MS, Wayne A. Rosenkrans, Jr., PHD, Michael W. Kattan, PHD
Journal: Diabetes Care
Diabetes Care 2009;32(5):e61
https://doi.org/10.2337/dc09-0327
Published: 01 May 2009
View article titled, Predicting 6-Year Mortality Risk in Patients With Type 2 Diabetes: <subtitle>Response to Paul et al.</subtitle>
Open the PDF for Predicting 6-Year Mortality Risk in Patients With Type 2 Diabetes: <subtitle>Response to Paul et al.</subtitle> in another window
Journal Articles

Predicting 6-Year Mortality Risk in Patients With Type 2 Diabetes

Brian J. Wells, MD, Anil Jain, MD, Susana Arrigain, MA, Changhong Yu, MS, Wayne A. Rosenkrans, Jr., PHD, Michael W. Kattan, PHD
Journal: Diabetes Care
Diabetes Care 2008;31(12):2301–2306
https://doi.org/10.2337/dc08-1047
Published: 01 December 2008
View article titled, Predicting 6-Year Mortality Risk in Patients With Type 2 Diabetes
Open the PDF for Predicting 6-Year Mortality Risk in Patients With Type 2 Diabetes in another window
Includes: Supplementary data